Table 2 Fever, improvement of QoL and HBV-DNA in trials included in the analysis

Non - CIK

CIK

Fever

0

12.40%

0.07

0.01 - 0.53

0.010

QOL improvement

58.54%

76.83%

0.32

0.16 - 0.64

0.001

QOL stability

31.70%

19.51%

2.52

1.22 - 5.20

0.010

QOL deterioration

9.76%

3.66%

2.91

0.79 - 10.64

0.110

HBV-DNA (> 1 × 10³ copy/ml)

91.30%

27.59%

27.50

5.21 - 145.15

< 0.010